SightfileU.S. market data from official filings

Companies › PLSE

PULSE BIOSCIENCES INC (PLSE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001625101 · EDGAR filings · Updated 2026-06-15

PULSE BIOSCIENCES INC (PLSE) has reported institutional ownership of 11.4%, with 96 institutional managers holding positions valued at $167.6M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
11.4%
Institutional managers
96
Reported 13F value
$167.6M
Insider activity
37 trans.
−$2.94M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PULSE BIOSCIENCES INC has 96 institutional holders and institutional ownership of 11.4%.

Insider activity

Insiders reported 37 transactions (3 buys, 17 sells) across 3 reporting insiders, with a net reported value of −$2.94M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2024-05-07 (recurring since 2020-03-16) — source filing. The authoritative details are those stated in the filing itself.

Related companies

LINEAGE CELL THERAPEUTICS IN (LCTX) · CAMP4 THERAPEUTICS CORP (CAMP) · ORASURE TECHNOLOGIES INC (OSUR) · NIAGEN BIOSCIENCE INC (NAGE) · EUPRAXIA PHARMACEUTICALS INC (EPRX) · IMMUNEERING CORP (IMRX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.